These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17976126)

  • 41. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.
    Lefaucheur C; Suberbielle-Boissel C; Hill GS; Nochy D; Andrade J; Antoine C; Gautreau C; Charron D; Glotz D
    Contrib Nephrol; 2009; 162():1-12. PubMed ID: 19001809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
    Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P
    Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation.
    Grabhorn E; Binder TM; Obrecht D; Brinkert F; Lehnhardt A; Herden U; Peine S; Nashan B; Ganschow R; Briem-Richter A
    Transplantation; 2015 Sep; 99(9):1876-81. PubMed ID: 25706279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The strength of donor-specific antibody is a more reliable predictor of antibody-mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients.
    Mujtaba MA; Goggins W; Lobashevsky A; Sharfuddin AA; Yaqub MS; Mishler DP; Brahmi Z; Higgins N; Milgrom MM; Diez A; Taber T
    Clin Transplant; 2011; 25(1):E96-102. PubMed ID: 20977497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
    Gandhi MJ; DeGoey SR; Bundy K; Kremers WK; Knauer R; Pereira N; Edwards B; Kushwaha S; Daly RC
    Transplant Proc; 2011 Dec; 43(10):3840-6. PubMed ID: 22172857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
    Ixtlapale-Carmona X; Arvizu A; De-Santiago A; González-Tableros N; López M; Castelán N; Marino LA; Uribe-Uribe NO; Contreras AG; Vilatobá M; Morales-Buenrostro LE; Alberú J
    Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience.
    Ozawa M; Rebellato LM; Terasaki PI; Tong A; Briley KP; Catrou P; Haisch CE
    Clin Transpl; 2006; ():265-90. PubMed ID: 18365384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies.
    Vaidya S; Partlow D; Barnes T; Thomas P; Gugliuzza K
    Clin Transplant; 2006; 20(4):461-4. PubMed ID: 16842522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes.
    Cooper JE; Gralla J; Cagle L; Goldberg R; Chan L; Wiseman AC
    Transplantation; 2011 May; 91(10):1103-9. PubMed ID: 21403588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel biomarker combination predicts long-term allograft outcome.
    Cail J; Huang W; Terasaki PI; Everly MJ; Briley KP; Haisch CE; Bolin P; Kendrick WT; Kendrick SA; Morgan C; Harland RC; Rebellato LM
    Clin Transpl; 2013; ():319-24. PubMed ID: 25095524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Donor-specific HLA antibody response in clonal deletion.
    Kaneku H; Idica A; Everly MJ; Terasaki PI; Feroz A; Vanikar AV; Shankar V; Trivedi VB; Modi PR; Khemchandani SI; Dave SD; Trivedi HL
    Clin Transpl; 2008; ():189-98. PubMed ID: 19708456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection.
    Reinsmoen NL; Cornett KM; Kloehn R; Burnette AD; McHugh L; Flewellen BK; Matas A; Savik K
    Transplantation; 2008 Feb; 85(3):462-70. PubMed ID: 18301338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?
    Gupta A; Iveson V; Varagunam M; Bodger S; Sinnott P; Thuraisingham RC
    Transplantation; 2008 Apr; 85(8):1200-4. PubMed ID: 18431242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
    Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
    Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.